STAT+: Pharmalittle: We’re reading about a reticent FDA commish nominee, a Novo deal, and more

<iframe
  src="https://statesidedaily.com/embed/cluster/281f3cc190d776f196ef93255434f091e5f4f02b"
  width="100%" height="320"
  style="border:0;max-width:680px"
  loading="lazy"
  title="STAT+: Pharmalittle: We&#8217;re reading about a reticent FDA commish nominee, a Novo deal, and more"></iframe>